102 related articles for article (PubMed ID: 28616911)
1. [Histone Deacetylation Down-regulates the Expression of
Liu JB; Wang HZ; Liu ZH; Xu M; Li X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):384-388. PubMed ID: 28616911
[TBL] [Abstract][Full Text] [Related]
2. Expression and epigenetic regulatory mechanism of BNIP3 in clear cell renal cell carcinoma.
Shao Y; Liu Z; Liu J; Wang H; Huang L; Lin T; Liu J; Wei Q; Zeng H; He G; Li X
Int J Oncol; 2019 Jan; 54(1):348-360. PubMed ID: 30365137
[TBL] [Abstract][Full Text] [Related]
3. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.
Kanao K; Mikami S; Mizuno R; Shinojima T; Murai M; Oya M
J Urol; 2008 Sep; 180(3):1131-6. PubMed ID: 18639283
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.
Wei M; Mao S; Lu G; Li L; Lan X; Huang Z; Chen Y; Zhao M; Zhao Y; Xia Q
BMC Cancer; 2018 Apr; 18(1):434. PubMed ID: 29665787
[TBL] [Abstract][Full Text] [Related]
5. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G
Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061
[TBL] [Abstract][Full Text] [Related]
6. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
[TBL] [Abstract][Full Text] [Related]
8. Selective silencing of the hypoxia-inducible factor 1 target gene BNIP3 by histone deacetylation and methylation in colorectal cancer.
Bacon AL; Fox S; Turley H; Harris AL
Oncogene; 2007 Jan; 26(1):132-41. PubMed ID: 16799636
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of BNIP3 in clear cell renal cell carcinoma].
Huang L; Zhao T; Tian YY; Wang HZ; Chen XQ; Xu M; Li X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):396-9. PubMed ID: 24941804
[TBL] [Abstract][Full Text] [Related]
10. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
[TBL] [Abstract][Full Text] [Related]
11. [Expression of BNIP3 and its correlations to HIF-1alpha and VEGF in clear cell renal cell carcinoma].
Luo L; Xiong ZB; Zeng H; Chen N; Chen XQ; Zhang P; Li X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):79-82. PubMed ID: 22455137
[TBL] [Abstract][Full Text] [Related]
12. BNIP3 induces apoptosis and protective autophagy under hypoxia in esophageal squamous cell carcinoma cell lines: BNIP3 regulates cell death.
Ma Z; Chen C; Tang P; Zhang H; Yue J; Yu Z
Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859361
[TBL] [Abstract][Full Text] [Related]
13. Regulation of
Zhu Q; Yu L; Qin Z; Chen L; Hu H; Zheng X; Zeng S
Epigenetics; 2019 Aug; 14(8):791-803. PubMed ID: 31088315
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg3 inhibits renal cell carcinoma cell migration, invasion, colony formation, and tube formation and enhances apoptosis through promoting the DNA demethylation and histone acetylation.
Ma Z; Zuo Y; Wang W
J Pharm Pharmacol; 2023 Jan; 75(1):76-86. PubMed ID: 36264186
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits ACHN cells via regulation of histone acetylation.
Dai L; Chen L; Wang W; Lin P
Pharm Biol; 2020 Dec; 58(1):231-238. PubMed ID: 32202448
[No Abstract] [Full Text] [Related]
16. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
Duan H; Heckman CA; Boxer LM
Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
[TBL] [Abstract][Full Text] [Related]
17. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer.
Okami J; Simeone DM; Logsdon CD
Cancer Res; 2004 Aug; 64(15):5338-46. PubMed ID: 15289340
[TBL] [Abstract][Full Text] [Related]
18. Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells.
Juengel E; Dauselt A; Makarević J; Wiesner C; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
Cancer Lett; 2012 Nov; 324(1):83-90. PubMed ID: 22579787
[TBL] [Abstract][Full Text] [Related]
19. Acetylation- and ubiquitination-regulated SFMBT2 acts as a tumor suppressor in clear cell renal cell carcinoma.
Xie Q; Hu B; Li H
Biol Direct; 2024 May; 19(1):37. PubMed ID: 38734627
[TBL] [Abstract][Full Text] [Related]
20. Histone H3 Lysine 4 Trimethylation, Lysine 27 Trimethylation, and Lysine 27 Acetylation Contribute to the Transcriptional Repression of Solute Carrier Family 47 Member 2 in Renal Cell Carcinoma.
Yu Q; Liu Y; Zheng X; Zhu Q; Shen Z; Wang H; He H; Lin N; Jiang H; Yu L; Zeng S
Drug Metab Dispos; 2017 Jan; 45(1):109-117. PubMed ID: 27821436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
